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Background: Safe and cost-effective programs for implementing
early infant male circumcision (EIMC) in Africa need to be piloted.
We present results on a relative cost analysis within a randomized
noninferiority trial of EIMC comparing the AccuCirc device with
Mogen clamp in Zimbabwe.
Methods: Between January and June 2013, male infants who met
inclusion criteria were randomized to EIMC through either
AccuCirc or Mogen clamp conducted by a doctor, using a 2:1
allocation ratio. We evaluated the overall unit cost plus the key cost
drivers of EIMC using both AccuCirc and Mogen clamp. Direct
costs included consumable and nonconsumable supplies, device,
personnel, associated staff training, and environmental costs.
Indirect costs comprised capital and support personnel costs. In
1-way sensitivity analyses, we assessed potential changes in unit
costs due to variations in main parameters, one at a time, holding all
other values constant.
Results: The unit costs of EIMC using AccuCirc and Mogen
clamp were $49.53 and $55.93, respectively. Key cost drivers were
consumable supplies, capacity utilization, personnel costs, and
device price. Unit prices are likely to be lowest at full capacity
utilization and increase as capacity utilization decreases. Unit
prices also fall with lower personnel salaries and increase with
higher device prices.
Conclusions: EIMC has a lower unit cost when using AccuCirc
compared with Mogen clamp. To minimize unit costs, countries
planning to scale-up EIMC using AccuCirc need to control costs of
consumables and personnel. There is also need to negotiate a reason-
able device price and maximize capacity utilization.
Key Words: AccuCirc, cost, early infant male circumcision, Mogen
clamp, Zimbabwe
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INTRODUCTION
Results from 3 randomized controlled trials indicate that
voluntary medical male circumcision (VMMC) can reduce the
risk of HIV infection among men by up to 60%.1–3 These
findings and those from other studies suggesting that VMMC
is cost-effective4–6 have led 14 African countries to scale-up
VMMC in an effort to reduce the number of new HIV
infections plus the overall costs of combating HIV/AIDS.5–9
Some of these countries, Zimbabwe included, have begun to
pilot early infant male circumcision (EIMC).10–15
The World Health Organization (WHO) and UNICEF
recommend EIMC (performed #60 days of life) for pre-
vention of HIV in countries with high HIV prevalence.16,17
EIMC is a quick and simple procedure, characterized by
complete wound healing within 7 days and accompanied by
a low rate of adverse events (AEs).18 Integrating EIMC within
existing child health services in resource-limited settings is
likely to be easier and less costly than establishing parallel
programs because EIMC can be combined with existing
routine postnatal or expanded immunization programs. With
adequate training, EIMC can be performed by nonphysician
providers, thereby minimizing the strain on human resources
for health.17
The Gomco clamp, Plastibell, and Mogen clamp are the
3 EIMC devices currently prequalified by WHO.18 These 3
devices are characterized by rare, but potentially serious,
complications, including laceration of the glans penis if
a mismatch in sizes of the separate pieces of the Gomco
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clamp occurs,13,18 the possibility of partial or total amputation
of the glans penis with Mogen clamp,15,18–20 and necrosis of
the glans and other injuries if migration of the Plastibell
occurs during circumcision.12,18,21,22 Use of incorrect “bell”
size can actually increase this risk.12,18,21,22 A relatively new
device, AccuCirc, can potentially reduce these device-related
AEs, as it has a shielding ring that protects the glans penis
from possible laceration or amputation. In addition, it comes
prepackaged and is disposable, factors which make it appeal-
ing for use in sub-Saharan Africa, particularly in resource-
limited rural settings where health centers may lack electricity
and sterilization equipment.13 AccuCirc is also suitable for use
by midlevel personnel such as nurse midwives who are in
greater supply than medical doctors in many HIV-affected
countries.13,23 Thus, in sub-Saharan Africa, AccuCirc may
provide a safer, more acceptable, feasible, and less costly
alternative to the already prequalified EIMC devices.
As part of the WHO male circumcision device pre-
qualification process,24 AccuCirc is undergoing pilot study in
countries where EIMC rollout is intended, including Zim-
babwe. Between January and June 2013, a randomized non-
inferiority EIMC pilot trial was conducted in Zimbabwe to
assess the safety, acceptability, feasibility, and cost of
AccuCirc compared with the Mogen clamp.25 This comparison
was chosen because the WHO prequalification process
requires that any new EIMC device be compared with an
already prequalified device.24 Of the 3 already prequalified
devices, the Mogen clamp is perceived to be the safest.10,12
Here, we present results of a cost analysis conducted alongside
the EIMC comparative trial to determine the relative cost
profile of AccuCirc compared with Mogen clamp.
METHODS
Trial methods are described in detail elsewhere.25 In
brief, 150 male infants aged 6–60 days were randomized to
AccuCirc or Mogen clamp in a 2:1 ratio (100 AccuCirc; 50
Mogen clamp) and followed for 2 weeks after circumcision.
The EIMC trial was conducted at Edith Opperman, a poly-
clinic in Zimbabwe’s capital, Harare. The polyclinic has the
highest number of deliveries in Zimbabwe (approximately
400 deliveries per month).26 Primary outcomes for the trial
were EIMC safety, acceptability, and cost.
Direct and indirect cost data were analyzed using the
Decision Makers Program Planning Tool (DMPPT) for
Costing Male Circumcision Programmes.27 DMPPT is a Mi-
crosoft Excel–based model developed by the US Agency for
International Development Health Policy Initiative in collab-
oration with the Joint United Nations Programme on HIV/
AIDS (UNAIDS) to assist decision makers understand the
potential cost and impact of various options for male
circumcision scale-up.
Direct costs included consumable and nonconsumable
supplies, device, personnel, associated staff training, and
environmental costs. Indirect costs comprised capital and
support personnel costs. This analysis adopted the perspective
of the Zimbabwe Ministry of Health as a health care payer.
Client costs such as transport to and from the EIMC facility,
opportunity costs of time spent seeking EIMC services and
caregiver costs were therefore excluded. Costs of demand
creation were also excluded. As our cost analysis is based on
a pilot EIMC study, we estimated our costs based on the
assumption of a vertical EIMC program. We present costs in
2013 constant US dollar prices and assume an exchange rate
of US$1 = US$1 because Zimbabwe officially adopted the
US dollar as its principal currency in 2009.
Collection, Management, and Analysis of
Cost Data
Detailed cost data collection was performed between
January and June 2013 guided by the UNAIDS Costing
Guidelines for HIV Prevention Strategies from which eco-
nomic data collection instruments were adapted.23
Facility Inventory
A list of all resources required to perform an EIMC
procedure using AccuCirc and Mogen clamp was identified
during a facility inventory conducted at the beginning of the
study. Resources included supplies, devices, capital equip-
ment, and staff. Resource-use data were collected routinely
during the trial, including quantity of supplies and devices
used, procedure duration, and quantity of waste. Actual usage
of supplies was recorded in a supplies charge sheet main-
tained in each infant’s binder. Total usage of each consum-
able item was derived by aggregating these records.
Time Spent Performing EIMC Tasks
Procedure duration was measured through a time and
motion study conducted alongside procedures. A stopwatch
was used to measure procedure duration that was recorded on
a study form. To verify the recorded time, a video camera
recorded the entire procedure. Total procedure time was
therefore based on direct and continuous observation of the
procedure.
Direct Costs
Consumable and Nonconsumable Supplies
Actual costs of supplies used were based on actual
invoices and receipts from research partners. Total number of
units of each supply item used was multiplied by its price per
unit to produce the total cost for that item. Total costs of all
supply items were then summed up, and the grand total was
divided by the number of procedures to derive the cost
contribution of supplies to each procedure.
Device Costs
For device costs, we relied on purchase prices as quoted
by the international suppliers. The price of an AccuCirc
device, based on an invoice by Clinical Innovations, was $10
per unit, which also represented the per procedure cost given
that AccurCirc is a single-use device. Mogen clamps were
supplied by Sklar Instruments at a unit price of $213.15.
Unlike AccuCirc, the Mogen clamp is reusable up to 1000
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times.7 Therefore, we divided its price per unit across 1000
EIMC procedures to derive its cost per EIMC.
Personnel Training Costs
The EIMC team (4 doctors and 3 nurse midwives)
received four 8-hour days of training. For each device, we
assumed that training would still require the same amount of
time and therefore allocated the full four 8-hour days to each
device in our cost analyses. Our estimates are however likely
to be a conservative estimate of the training costs. Training
kits were supplied at no cost by the supplier as they come
complimentary for large orders. However, for purposes of
calculating training costs and upon request, the supplier
provided a quotation for training materials. While doctors
received an hourly rate for attending training equivalent to
what they would have earned for providing an EIMC
procedure, study nurse midwives did not as they were already
on a monthly salary. However, in view of the fact that
government nurse midwives normally receive a daily allow-
ance for attending training workshops, it was necessary to
calculate the opportunity cost of time they spent at training for
which we used their hourly salary rate.
Total training costs therefore comprised fees for 2
consultant trainers, costs of time spent by doctors and nurse
midwives at training, and costs of training materials plus
catering. To estimate annual training costs, the study team
adopted an approach used in a Zimbabwe PrePex device cost
study where annual turnover among public sector nurse
midwives in Zimbabwe was estimated at 50%, necessitating
training of a new team every 3.6 years.28 Total training costs
were therefore spread over a 3.6-year period to derive an
annual training cost. The per EIMC training cost was
calculated by dividing the annual training cost by the annual
number of EIMC procedures (1512). EIMC training took
place in the study clinic boardroom, and as scale-up is
anticipated to use government personnel and facilities, we
excluded travel and training venue costs.
Personnel Costs
As EIMC was still at the pilot stage, we relied on
salaries of EIMC staff to calculate personnel costs. Doctors’
salaries comprised basic pay and benefits ($31,800 per year),
whereas nurse midwives’ salaries comprised basic pay plus
allowances [housing allowance ($45 per month) and transport
allowance ($65 per month)], amounting to $13,596 per year.
Hourly salary rates were computed by dividing annual salary
by annual number of hours worked. Hourly salary rates were
then multiplied by time contributed to the procedure, and
results for all staff members were summed up. In practice, in
an integrated EIMC scale-up, we anticipate that personnel
will have other clinic responsibilities in addition to EIMC
procedures, including among others, maternity services,
antenatal and postnatal care, voluntary counseling and testing,
and providing antiretroviral therapy. Furthermore, and based
on discussions with clinic facility managers and officials at
the Ministry of Health, we anticipate that EIMC will likely
consume a small proportion of staff effort and that allocating
10% of staff salaries to EIMC is a conservative estimate. In
sensitivity analyses, we therefore explored the impact of
assuming only 10% of total salary costs on EIMC unit cost.
Environmental costs
Environmental costs were calculated based on the
estimated number of burn bin (ie, sharps tin container)
disposals. For the AccuCirc procedures, a total of 18 burn
bins were used compared with 6 for the Mogen clamp.
Environmental costs for each device were derived by
multiplying the number of burn bins disposed by the cost
of incineration ($10 per burn bin), based on quotations
provided by private service providers.
Indirect Costs
Capital Costs (Buildings)
EIMC procedures were performed in a renovated space
in the clinic where the study took place. Because of this and
the likelihood of an integrated EIMC scale-up, our analysis
assumes zero physical infrastructure development costs for
a scaled-up EIMC program.
Capital Costs (Durable Equipment)
Clinic equipment used for EIMC procedures included
a refrigerator, a medium-size autoclave for sterilizing Mogen
clamps, and heaters to keep infants warm. Purchase prices of
each capital item were divided by an appropriate amortization
period to derive annualized depreciation values. Annualized
depreciation values for all capital goods were summed up, and
the grand total was divided by the annual number of EIMC
procedures. As an integrated EIMC scale-up is anticipated and
as this equipment is already found in government facilities, we
explored the effect of excluding durable capital equipment on
EIMC unit cost in sensitivity analyses.
Support Personnel Costs
Monthly gross salaries of support staff (clinic clerk and
caretaker), including benefits [housing allowance ($45 per
month) and transport allowance ($65 per month)], were
multiplied by 12 months to produce an annual salary of
$9492 and $7152, respectively. As support personnel are
involved in a range of clinic services, we assumed 10% of
each personnel type’s salary to support personnel costs and
summed up the contributions. Our model divides the result by
the annual number of EIMC procedures to derive the support
personnel contribution to EIMC unit cost.
One-Way Sensitivity Analyses
A number of factors could potentially introduce uncer-
tainty into our results. First, Clinical Innovations, the manu-
facturer of AccuCirc, has indicated that future supplies of the
device will be priced higher than $10. The unit cost of an
EIMC would therefore be much higher than that reflected here.
Also, in a future scale-up, poor demand for EIMC could
potentially raise EIMC unit cost. For instance, our cost analyses
were based on a daily maximum rate of 6 EIMC procedures,
whereas on the ground, the study team experienced challenges
in recruiting infants.25 Reduced EIMC uptake in a scaled-up
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program would lead to a failure to fully use facility capacity,
a situation which would raise unit cost of EIMC procedure.
Personnel salary costs for EIMC used here are based on
research study salaries, and therefore the cost results here
may not reflect those of a model that uses government
personnel salaries. In addition, we included durable capital
equipment costs in this analysis, although most clinics in
Zimbabwe already use the durable equipment required to
conduct an EIMC procedure for other clinical services. In
an integrated EIMC delivery model, durable capital equip-
ment may therefore not represent an additional cost because
that infrastructure already exists. These factors individually or
combined could potentially raise or lower the cost of an
EIMC procedure in a scaled-up EIMC program.
We therefore considered the sensitivity of results to
variations in the AccuCirc device unit price, personnel salaries,
and capacity utilization, one at a time, holding all other values
constant. Additionally, as the AccuCirc retail price has not yet
been determined by the manufacturer, we investigated the
exact price at which the AccuCirc unit cost would break even
with the Mogen clamp. As durable capital equipment is already
available in Zimbabwean clinics for other forms of health care,
we also tested the sensitivity of results if capital equipment was
excluded. In sensitivity analyses, we also estimated the unit
cost of an EIMC procedure if EIMC were integrated into
existing clinic programs such that medical personnel would
also provide other services in addition to EIMC.
Ethical Considerations
The study received approvals from the Medical
Research Council of Zimbabwe and the Ethics Committees
of the University College London and the London School of
Hygiene and Tropical Medicine.
RESULTS
In the EIMC comparative trial, 150 infants aged 6–54
days were circumcised between January and June 2013
according to their allocated intervention (n = 100 AccuCirc;
n = 50 Mogen clamp). The mean time taken to perform the
actual EIMC procedure was 15.5 minutes and was similar for
both devices {mean difference = 0.1 minutes [95% confi-
dence interval (CI): 21.2 to 1.4]}. Two moderate AEs (2%,
95% CI: 0.2 to 7.0) were observed in the AccuCirc arm.
These were one case of excess skin removal (hydrocortisone
cream applied and wound was completely healed 4 months
after EIMC) and one case of inadequate skin removal, which
warranted corrective surgery and was completely healed 20
days after corrective surgery. No AEs (95% CI: 0.0 to 7.1)
occurred in the Mogen clamp arm. Nearly all mothers
(99.5%) reported great satisfaction with the outcome. All
mothers, regardless of arm, said they would recommend
EIMC to other parents and would circumcise their next son.
Trial outcomes are described in detail elsewhere.25
Table 1 summarizes the results of cost analyses for both
AccuCirc and Mogen clamp. The unit costs of EIMC using
AccuCirc and Mogen clamp were $49.53 and $55.93,
respectively. Costs of consumable supplies were higher for
Mogen clamp ($30.18 compared with $13.48). This large
difference is explained by the fact that the prepackaged
AccuCirc kit comes with a number of consumable supplies
required for an EIMC procedure, and because AccuCirc is
disposable, it does not require the sterilization supplies
required for the Mogen clamp (Table 1). The contribution
of device cost was higher for AccuCirc, at $10, compared
with $0.21 for the reusable Mogen clamp.
Key cost contributors to the unit cost of AccuCirc were
consumable supplies, device price, and personnel costs. For
AccuCirc, consumable supplies ($13.48), device price ($10),
TABLE 1. EIMC Cost Components
Cost Category
AccuCirc Mogen Clamp
Cost (in $) Per EIMC % Contribution to Unit Cost Cost (in $) Per EIMC % Contribution to Unit Cost
Direct costs
Device 10.00 20.2 0.21 0.4
Consumable supplies 13.48* 27 30.18† 54
Nonconsumable supplies 0.27 0.5 0.31 0.6
Environmental 1.80 4 1.20 2
Personnel 19.11 39 19.11 34
Training 3.69 7 3.69 7
Subtotal (direct) 48.35 98 54.70 98
Indirect costs
Capital equipment 0.08 0 0.13 0
Support personnel 1.10 2 1.10 2
Subtotal (indirect) 1.18 2 1.23 2
Total 49.53 — 55.93 —
All costs are presented in 2013 US dollars.
*Sterile gloves, nonsterile gloves, antiseptic solution, 3 linen savers, EMLA topical cream, Vitamin K, wet wipes, liquid cleaner, cotton wool, methylated spirit, bin liners, baby
diapers, sharps tin containers, syringe 2 mL with needle, paper towels, hard surface cleaner, hand wash, hand cream.
†Sterile gloves, nonsterile gloves, antiseptic solution, 4 linen savers, surgical blade, sterile gauze pad, EMLA topical cream, autoclave sterilizing sensitive tape, sterile marker pen,
Vitamin K, autoclave sterilizing towels, paraffin gauze pad, petrolatum foil packs, wet wipes, syringe 2 mL with needle, liquid cleaner, cotton wool, methylated spirit, bin liners, baby
diapers, sharps tin containers, paper towels, hard surface cleaner, hand wash, hand cream.
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and personnel costs ($19.11) accounted for a combined
86.2% of EIMC unit cost. For Mogen clamp, key cost
contributors were consumable supplies ($30.18) and person-
nel costs ($19.11), which together contributed 88% to the unit
cost. The wide difference in consumable supplies costs
between the 2 devices reflects the cost-savings due to the
lower number of supplies costed for the AccuCirc procedure,
as a number of EIMC supplies come prepacked in the
AccuCirc kit already priced at $10. Overall, other direct costs
(training and environmental costs) and indirect costs (capital
equipment and support personnel costs) had a smaller
contribution to the total costs of EIMC for both devices.
Table 2 presents 1-way sensitivity analysis results and
demonstrates unit cost impacts for AccuCirc when the main
parameters (AccuCirc device price, capacity utilization, and
personnel salaries) are varied and also when capital equip-
ment is excluded. We explored EIMC unit cost impacts in an
integrated EIMC program where personnel time is shared
with other medical services in addition to EIMC. Results
show EIMC unit cost for AccuCirc rising from $49.53 to
$64.53 as device price increases from $10 to $25. The exact
price at which the AccuCirc unit cost would break even with
the Mogen clamp is $16.40. We also varied capacity
utilization between 2 and 6 procedures per day to study the
impact of low EIMC uptake (low capacity utilization). While
at maximum capacity utilization EIMC unit cost is $49.53,
when only 2 EIMC procedures are performed per day, EIMC
unit cost rises to $59.25.
As EIMC scale-up is likely to use government facilities,
in sensitivity analyses we tested the impact on unit cost if
lower civil service salaries were used rather than research
staff salaries. Results show that EIMC unit cost decreases
from $49.53 in the base case to $43.71 in the public sector.
Furthermore, as durable equipment required for EIMC
already exists in Zimbabwe’s public health facilities, we also
tested EIMC unit cost impacts when durable equipment is
excluded. However, as durable equipment has a relatively low
contribution to EIMC unit cost, excluding equipment costs
does not have a large impact on EIMC unit costs.
DISCUSSION
In this cost analysis, we sought to estimate the unit
costs of EIMC using the AccuCirc device and Mogen clamp,
establish key cost contributors, and potential changes in
EIMC unit costs, using AccuCirc, due to variations in the key
cost drivers. It would cost $49.53 to perform an EIMC
procedure in Zimbabwe using AccuCirc compared with
$55.93 using Mogen clamp in a vertical EIMC program. In
an integrated program (using 10% of staff salaries), AccuCirc
unit cost would be $30.26 compared with $36.61 for the
Mogen clamp. The key cost drivers are consumable supplies,
capacity utilization, personnel costs, and device price.
Considerable potential for reductions in EIMC unit cost
exists in the future. Given the high likelihood of an EIMC
scale-up integrated in government facilities, differences in
study and civil service personnel salaries would result in cost
differences. Moreover, in an integrated EIMC scale-up,
medical personnel costs are likely to come down because
they would be shared with other clinic services. Additionally,
in this trial, doctors conducted EIMC, whereas in practice,
EIMC with AccuCirc could be conducted using nurse mid-
wives; the safety and feasibility of using the latter providers
have been investigated in a field implementation study in
Harare.29 Furthermore, this model assumes that between 2
and 6 EIMCs are performed daily. In smaller or rural settings
where the number of deliveries per month is low, fewer
EIMCs would be undertaken. In these settings, the model for
delivering EIMC would need to be different from that costed
here and this would likely affect the cost per procedure.
Experiences from the trial that accompanied this study
indicated low EIMC uptake for a number of reasons, one of
which is that parental awareness of the fact that the 2 EIMC
devices were under study may have led (incorrectly) to doubts
about the safety of the procedure and consequently lowered
uptake.29 As our results also show, capacity utilization is
indeed an important cost driver. In sensitivity analyses, lower
levels of capacity utilization resulted in significantly higher
TABLE 2. One-Way Sensitivity Analysis Results for AccuCirc




Unit Cost (in $)
Mogen Clamp EIMC
Unit Cost (in $)
Device costs (in $)
10 (base case) 49.53 55.93
15 54.53 N/C




Base case 49.53 55.93
Public sector* 43.71 50.11
Salaries







6 (base case) 49.53 55.93
Capital equipment










Base case 49.53 55.93
+10% 50.88 58.95
*Public sector salaries inclusive of benefits are doctor ($26,400), nurse midwife
($8400), receptionist ($3000), and caretaker ($1800).
†10% of total salaries of doctors and nurse midwives.
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EIMC unit costs using AccuCirc (due to consequent increase
in costs of training, durable equipment, and support personnel
costs). However, acceptance of EIMC will likely rise as
greater numbers of procedures are performed and adult
VMMC continues to be scaled-up.29 With increased uptake,
the unit costs of EIMC are likely to decrease further. Demand
creation efforts will therefore be important to ensure efficient
use of EIMC services and achievement of lower unit costs
due to economies of scale.
The significance of the price of the AccuCirc device on
the unit cost of an EIMC procedure underscores the
vulnerability of the cost per procedure to the device price
that is ultimately negotiated. Clearly, it will be important to
negotiate a reasonable pricing structure with the manufacturer
before scale-up begins. As future scale-up assumes use of the
AccuCirc device, a significant increase in price such as the
one proposed is likely to adversely affect the possibility and
speed of EIMC scale-up. To the best of our knowledge, this is
the first study to explore actual costs of EIMC offered through
the AccuCirc device in sub-Saharan Africa. It is possible that
cost of EIMC in other contexts might differ from that
presented here. For example, a study that modeled direct
costs of EIMC in Rwanda using a hypothetical cohort of
150,000 infants found that infant male circumcision only
costs $15 using the Mogen clamp and was found to be a cost-
saving intervention overall.7 Our results show that an EIMC
procedure using the Mogen clamp costs $55.93.
It is important to note, however, that the Rwanda study
analyzed direct costs only (excluding environmental costs but
including demand creation and costs of AEs) of an integrated
model, where staff costs are shared with other clinic services,
whereas our study analyzed both direct and indirect costs
using a vertical model. Also, we included essential consum-
ables that were omitted in the Rwanda study (eg, surgical
blades, linen savers, wet wipes, and sterilization materials)
(Table 1). Moreover, our list of consumables included
Vitamin K (at $3.30), which is usually given routinely at
birth but is currently unavailable in Zimbabwe and is
expensive to import. Finally, our analyses included costs of
consumables at 3 follow-up visits (gloves, linen savers, wet
wipes, and paper towels), whereas the Rwanda study only
included consumables used during the circumcision itself. Of
note, in the sensitivity analysis conducted in the Rwandan
study, they only found the procedure to be cost-saving up to
a cost of $25 but that it was still highly cost-effective up to
$38.50, which is higher than $36.61 we found for scale-up in
an integrated program.
Limitations
This cost study has some limitations. First, EIMC
procedures were performed in a pilot study within an urban
setting, and therefore cost results may not reflect those of
a scaled-up program. In this context, we also assumed staff
dedicated to performing EIMC in a vertical program.
Particularly important to note is that the pilot study itself
lasted 6 months with a sample of 150 EIMC procedures. To
make this cost analysis possible, a number of assumptions
had to be made including use of an estimated annual number
of EIMC procedures and apportioning training costs over
a 3.6-year period to arrive at annual training costs. These
assumptions may not accurately reflect a scaled-up program
environment and, as a result, may either lead to higher or
lower procedure unit costs.
This cost study also excluded costs of a demand
creation campaign, which is especially important in a setting
like Zimbabwe where EIMC is a relatively new procedure
requiring extensive promotional activities. Further research
may be warranted in a scaled-up program to establish the
contribution of demand creation costs. Additionally, the site
for the pilot study had on-site incineration facilities for EIMC
waste disposal. Our environmental costs therefore excluded
transport costs and only included the costs of actual
incineration. In a scale-up situation, some clinics may not
have access to on-site incinerators, implying that trans-
portation of waste to other sites will need to be costed.
Utility costs (electricity and water supply) were also excluded
from the analyses, as they were deemed identical and unlikely
to affect the choice between the 2 devices. Finally, AEs were
also excluded from the analyses because the study experi-
enced only 2 moderate AEs, which resolved quickly.
Nonetheless, costs of AEs might be negligible, as EIMC-
related AEs are rare.18
CONCLUSIONS
Despite the stated limitations, this cost analysis of
EIMC using devices in Zimbabwe provides valuable data that
can inform which devices to use when scaling up EIMC and
determine overall resources needed to implement a scaled-up
EIMC program. It is important to adopt strategies, which
enable that costs of supplies and devices are contained to
ensure low EIMC costs. An extensive demand creation
campaign would need to be integral to scale-up in order to
provide economies of scale. Further research in other contexts
or alongside future scale-up should investigate impact of
different costs of supplies, different personnel structures, and
higher uptake rates that should result in substantial economies
of scale being gained.
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